AU2013201629B2 - Treating dyspnea associated with acute heart failure with relaxin - Google Patents

Treating dyspnea associated with acute heart failure with relaxin

Info

Publication number
AU2013201629B2
AU2013201629B2 AU2013201629A AU2013201629A AU2013201629B2 AU 2013201629 B2 AU2013201629 B2 AU 2013201629B2 AU 2013201629 A AU2013201629 A AU 2013201629A AU 2013201629 A AU2013201629 A AU 2013201629A AU 2013201629 B2 AU2013201629 B2 AU 2013201629B2
Authority
AU
Australia
Prior art keywords
relaxin
heart failure
acute heart
dyspnea associated
acute
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2013201629A
Other versions
AU2013201629A1 (en
Inventor
Gad Cotter
Dennis R. Stewart
Sam L. Teichman
Elaine Unemori
Martha Jo Whitehouse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corthera Inc
Original Assignee
Corthera Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009246114A external-priority patent/AU2009246114B2/en
Application filed by Corthera Inc filed Critical Corthera Inc
Priority to AU2013201629A priority Critical patent/AU2013201629B2/en
Publication of AU2013201629A1 publication Critical patent/AU2013201629A1/en
Application granted granted Critical
Publication of AU2013201629B2 publication Critical patent/AU2013201629B2/en
Priority to AU2016219717A priority patent/AU2016219717A1/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

H:\fmt\Intenvoven\NRPorbl\DCCPFvM4994325-1.DOC-15/03/2013 The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin.
AU2013201629A 2008-05-16 2013-03-19 Treating dyspnea associated with acute heart failure with relaxin Ceased AU2013201629B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2013201629A AU2013201629B2 (en) 2008-05-16 2013-03-19 Treating dyspnea associated with acute heart failure with relaxin
AU2016219717A AU2016219717A1 (en) 2008-05-16 2016-08-26 Treating dyspnea associated with acute heart failure with relaxin

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US61/127,889 2008-05-16
US61/190,545 2008-08-28
US61/201,240 2008-12-08
US61/164,333 2009-03-27
AU2009246114A AU2009246114B2 (en) 2008-05-16 2009-05-15 Treating dyspnea associated with acute heart failure with relaxin
AU2013201629A AU2013201629B2 (en) 2008-05-16 2013-03-19 Treating dyspnea associated with acute heart failure with relaxin

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2009246114A Division AU2009246114B2 (en) 2008-05-16 2009-05-15 Treating dyspnea associated with acute heart failure with relaxin

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2016219717A Division AU2016219717A1 (en) 2008-05-16 2016-08-26 Treating dyspnea associated with acute heart failure with relaxin

Publications (2)

Publication Number Publication Date
AU2013201629A1 AU2013201629A1 (en) 2013-04-11
AU2013201629B2 true AU2013201629B2 (en) 2016-07-21

Family

ID=48083706

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013201629A Ceased AU2013201629B2 (en) 2008-05-16 2013-03-19 Treating dyspnea associated with acute heart failure with relaxin

Country Status (1)

Country Link
AU (1) AU2013201629B2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166191A (en) * 1991-08-19 1992-11-24 Genentech, Inc. Use of relaxin in cardiovascular therapy

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166191A (en) * 1991-08-19 1992-11-24 Genentech, Inc. Use of relaxin in cardiovascular therapy

Also Published As

Publication number Publication date
AU2013201629A1 (en) 2013-04-11

Similar Documents

Publication Publication Date Title
MX2010012450A (en) Treating dyspnea associated with acute heart failure with relaxin.
MX336145B (en) Method of treating chronic heart failure.
AU2016202421B2 (en) Method of treating neurological conditions with cardiac glycosides
MX2010003217A (en) Angiogenic cells from human placental perfusate.
EP2498797A4 (en) Treatment of heart disease
WO2010151755A3 (en) TREATMENT OF INFLAMMATORY DISEASES USING miR-124
MY165160A (en) TREATMENT OF MYOCARDIAL INFARCTION USING TGF-ß ANTAGONISTS
MX2015015036A (en) Methods for improving lipid profiles using atrasentan.
AU2016219717A1 (en) Treating dyspnea associated with acute heart failure with relaxin
MX2010006443A (en) Treatment of heart disease using î²-blockers.
AU2013201629B2 (en) Treating dyspnea associated with acute heart failure with relaxin
WO2009105756A3 (en) Protection of neural retina by reduction of rod metabolism
PH12016500711A1 (en) Method of treating dyspnea associated with acute heart failure
TN2010000504A1 (en) Treating dyspnea associated with acute heart failure with relaxin
CU20100225A7 (en) TREATMENT OF DISNEA ASSOCIATED WITH ACUTE CARDIAC INSUFFICIENCY WITH RELAXIN
Reynolds Cardiac resynchronization for heart failure: Its time has come
UA49534U (en) Method for optimizing treatment of heart failure in aged patients after myocardial infarction
UA60249U (en) Method for treating acute myocardial infarction
UA40165U (en) Method for evaluation of level of cortizol in patients with ischemic cardiac disease
UA41944U (en) Method for predicting survival of patients with chronic heart insufficiency and systolic dysfunction of left ventricle
UA58755U (en) method for TREATMENT of patients with non-alcohol steatohepatitis COMBINED WITH diabetes mellitus of the 2 type
UA46804U (en) Method for assessing level of vasopressin in chronic cardiac failure
UA69687U (en) method for rehabilitation of patients with peptic duodenal ulcer in combination with coronary heart disease
UA107447C2 (en) Method for assessment of the anti-anginal effect of propranolol in patients with coronary heart disease with angina and hypertension with "hypertrophic" type diastolic dysfunction of the left ventricle
UA41582U (en) Method for increasing efficacy of recovering sinus rhythm in patients with persisting form of atrial flatter

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired